Skip to content
Events

Details

This support webinar discusses the NextSeq 1000 and 2000 sequencers and reagents, including the introduction of XLEAP-SBS™ chemistry, pre-run considerations, run setup, run start best practices, run metrics review, and maintenance. This webinar is for anyone who wants to learn more about the NextSeq 1000/2000 Run Quality and Best Practices.

Speaker:

Vijay Bhaskarla
Staff Technical Applications Scientist,
Illumina

Vijay graduated from the RMIT University, Australia in 2017 with a PhD in Applied Genomics. His main role as Technical Application Scientist at Illumina is to provide instrumentation and informatics support to Illumina customers in the Asia Pacific region. He has extensive experience in NGS data analysis that includes RNA-Seq, Methylation and Metagenomics.
Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
1 Apr 2024
Location
Europe
Topic
Cancer research, Cellular & molecular biology, Agrigenomics, Complex disease genomics, Consumer genomics, Forensic genomics, Genetic & rare diseases, Drug discovery & development, Immunology, Immuno-oncology research, Microbial genomics, Neuroscience, Oncology, Reproductive health, Transplant genomics, Pharmacogenomics, Precision health, Population genomics
Watch Now

Related Events

Feb 24
Alzheimer's Research UK Conference (ARUK 2026)
24 Feb 2026 – 25 Feb 2026
Illumina will be exhibiting at the Alzheimer's Research UK Conference (ARUK 2026) on the 24th & 25th February 2026
View Event
Feb 25
Irish Association for Cancer Research 62nd Annual Scientific Conference 2026
25 Feb 2026 – 27 Feb 2026
Illumina will be exhibiting at the IACR 62nd Annual Scientific Conference on the 25-27th February 2026
View Event
Feb 26
BaseSpace™ Sequencing Hub: FASTQ Processing Tools for Data Analysis
26 Feb 2026
An overview of Illumina FASTQ generation tools and highlight the differences between Illumina run performance metrics and output generated by third party tools such as FASTQC.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.